case_images: PMC4996991_01
case_images: Pelvic magnetic resonance image. Sagittal T2-weighted magnetic resonance image showing endometrial cancer as heterogeneous intermediate-signal intensity lesion (white asterisk) disrupting the normal high-signal intensity endometrium and infiltrating less than half of the ventral myometrial thickness (revised FIGO IA Stage).
case_images: fonc-06-00190-g001.jpg
case_images: PMC4996991_01_fonc-06-00190-g001.jpg
case_images: F1
case_images: T2-weighted image a 2 cm x 2.5 cm area of heterogeneous intermediate-signal intensity lesion disrupting the normal high-signal intensity endometrium and invading less than half of the myometrium (Figure 1). Then, in January 2015, she underwent hysterectomy and bilateral oophorectomy.
case_images: Histology of the primary endometrial cancer and the ileum recurrence. (A) Moderately differentiated endometrioid adenocarcinoma (G2). Superficial myometrial invasion of the tumor (arrow) (hematoxylin-eosin staining, x20). (B) Endometrioid adenocarcinoma metastating to the ileum. The tumor invades bowel mucosa (arrow) and stroma connective adipose subserous (hematoxylin-eosin staining, x20).
case_images: fonc-06-00190-g002.jpg
case_images: PMC4996991_01_fonc-06-00190-g002.jpg
case_images: F2
case_images: The final histopathology reported a 2 cm x 1 cm G2 endometrioid EC with a 30% myometrial deep invasion (FIGO Stage 1A) (Figure 2A). The final histopathology was positive for EC recurrence at ileum, omentum, and vaginal wall (Figure 2B).